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Abstract: Genetic variants associated with human dis-
eases are often located outside the protein coding regions
of the genome. Identification and functional characteriza-
tion of the regulatory elements in the non-coding genome
is therefore of crucial importance for understanding the
consequences of genetic variation and the mechanisms of
disease. The past decade has seen rapid progress in high-
throughput analysis and mapping of chromatin accessi-
bility, looping, structure, and occupancy by transcription
factors, as well as epigenetic modifications, all of which
contribute to the proper execution of regulatory functions
in the non-coding genome. Here, we review the current
technologies for the definition and functional validation
of non-coding regulatory regions in the genome.
Keywords: non-coding genome, cis-regulatory regions,
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Introduction
Completion of the human genome sequence [1], which
contains roughly 3.3 billion nucleotides, quickly led to the
recognition that only about 2% of the human genome
is protein coding, while the remaining nearly 98% do
not code for proteins. Functional high-throughput studies
have indicated that a considerable fraction of non-coding
sequences, with estimates on the order of 5–10%, har-
bor key functional elements responsible for the regula-
tion of complex temporal and tissue-specific gene expres-
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sion in different cell types of the human body [2]. Genome-
wide association studies (GWAS) have mapped numerous
loci that are associated with complex phenotypic traits.
More than 90%of these GWAS variants are located in non-
coding regions of the genome clustering in andaround reg-
ulatory elements. How these variants act on the phenotype
has thus fuelednew interest into the functional interaction
between these quantitative trait loci (QTLs) and their asso-
ciated genes [3].
With the genome sequence available, the next press-
ing challengeswere to annotate all gene regulatory regions
and understand their function. Due to the rapid progress
in DNA sequencing technologies over the course of the last
decade, combined with the development of novel in sil-
ico analysis and modeling tools, our understanding of the
non-coding human genome has finally advanced to the
point where we can begin to address these challenges.
Transcriptional regulatory regions, also referred to as
cis-regulatory regions or modules, are often grouped into
promoters, enhancers, and insulators. Promoters are prox-
imal regions around the transcription start sites (TSSs)
of genes which contain DNA elements that recruit the
basal transcriptional factors (TFs) and, ultimately, RNA
Polymerase II (RNAP II), setting in motion the transcrip-
tion machinery. Enhancers are distal cis-regulatory re-
gions that recruit sequence-specific TFs along with chro-
matin remodeling co-factors, thereby exerting an influ-
ence on the transcription initiation at the promotor.
Aprominent feature of enhancers is their key role in tissue-
specific gene expression. Highly regulated genes can be
influenced by up to several dozen enhancers [4, 5]. Their
coordinated activity with promoters dictates the dynamic
temporal and spatial regulation of transcriptional pro-
grams in different cell types.
To this end, proximal and distal regions contain sev-
eral short sequence elements called TF binding sites
(TFBSs) that attract specific TFs (see Leitz et al., this is-
sue). Distal regions with an effect on gene transcription
can be located downstream or upstream of the promoter,
as well as inside the gene or at a large distance ranging
from hundreds to tens of thousands of nucleotides. Fi-
nally, insulators act as barriers to prevent the spread of
heterochromatin and to block distal regions from acting
on unrelated promoters. In vertebrate cells, this enhancer-
restrictive function of insulators is mediated by binding
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Figure 1:Model of promoter–enhancer interaction in a chromatin loop extruded by the cohesin complex. (A and B) The ring-shaped ATPase
cohesin complex initiates the extrusion of the chromatin fiber and keeps translocating along the chromatin, forming a DNA loop in the pro-
cess. (C) Translocating cohesin stops at a pair of convergent CTCF sites that form the boundary of the chromatin loop or the TAD. The CTCF
sites have to be in a proper orientation to each other in order to stop cohesin. (D) Enhancers and promoters within a single loop are prone
to interaction due to proximity, resulting in the recruitment of transcription factor(s) and of RNA polymerase II, thereby initiating gene tran-
scription.
of the CCCTC-binding factor (CTCF), which plays a cru-
cial role in organizing the genome into topologically as-
sociating domains (TADs) [6]. Currently, the generation
of TADs is best explained by the loop extrusion model
(Figure 1A–C), where the ring-shaped cohesin complex
pinches a loop out of the chromatin fiber and continues
to propel chromatin via its ATPase activity until it reaches
a pair of convergent CTCF sites. Promoters and enhancers
within a loop are prone to interaction due to proxim-
ity (Figure 1D). Notably, while enhancers are the primary
drivers for cell type-specific gene expression programs, in-
sulator positions have largely been found to be similar in
different cell types.
Regulatory regions of the genome are marked by epi-
genetic signals, which comprise DNA methylation and
chemical modifications of the histones. Eukaryotic DNA is
tightly packed into chromatin by means of nucleosomes,
consisting of 147 bp of DNA wrapped around a histone oc-
tamer, separated by stretches of linker DNA. Modification
of these histones by means of methylation or acetylation
has an influence on the packing density and accessibil-
ity of the chromatin. Unlike the underlying static DNA se-
quence, these modifications can dynamically respond to
and alter the cellular states. Specific epigenetic modifica-
tions and their particular combinations, the so-called “hi-
stone code” [7], are associated with distinct genomic reg-
ulatory features and their activity states [8], providing key
spatial and temporal functional information.
In this review, we focus on genome-wide approaches
for defining genomic regulatory regions, including high-
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throughput profiling of open chromatin, epigenomic
marks, and long-range promoter–enhancer interactions.
We also discuss advances in the genome and epigenome
editing assays for functional analyses of the identified can-
didate regulatory regions, enabling their validation for po-
tential causal roles in target gene regulation.
Annotation of candidate regions
Accessible chromatin: From DNase- to
ATAC-seq
In addition to being the structural core unit of chro-
matin, nucleosomes and their positioning throughout the
genome have pivotal functions for regulating the acces-
sibility of binding sites to TFs and the basal transcrip-
tional machinery. During transcriptional activation, bind-
ing of TFs, orchestrated by the action of histone remod-
elers, results in the destabilization of nucleosomes at cis-
regulatory regions. Accessible regions of the genome are
therefore the primary genomic candidates for harboring
regulatory elements and have been historically character-
ized based on their hypersensitivity to DNase I digestion
[9].
DNase I hypersensitivity forms the basis of DNase
I-hypersensitive sites sequencing (DNase-seq), a method
for the genome-wide andhigh-throughput identificationof
DNase I-hypersensitive sites [10]. DNase-seq has become
a standard technique for probing chromatin accessibility
and was extensively used by the ENCODE [11] and Epige-
nomics Roadmap [12] consortia to study cell-specific chro-
matin accessibility and its relation to gene expression in
numerous cell and tissue types.
Since its introduction in 2013, the assay for transpos-
ase-accessible chromatin using sequencing (ATAC-seq)
has increasingly replaced DNase-seq as a fundamental
tool for genome-wide mapping of open chromatin regions
[13]. ATAC-seq uses a genetically engineered hyperactive
Tn5 transposase that is capable of inserting DNA sequenc-
ing adapters specifically into regions of open chromatin.
This allows targeted PCR amplification of open chromatin
fragments, followed by subsequent construction of a next-
generation sequencing (NGS) library,which represents the
entirety of open chromatin. ATAC-seq has risen in pop-
ularity due to its simple and time-efficient protocol and
substantially lower amount of required starting material,
ranging from 500 to 50,000 cells, while generating data
with comparable sensitivity and specificity as DNase-seq.
Because the ATAC-seq protocol does not involve any size
selection steps, it can simultaneously identify nucleosome
positions and accessible regions. As ATAC-seq can work
with little source material, it is an ideal tool for projects
with limited sample availability, such as investigation of
differentiated cells derived from induced pluripotent stem
cells (iPSCs) and patient specimens.
The binding of regulatory factors within accessible re-
gions leaves a so-called “footprint,” i. e., a region of the
DNA that is occupied by the TF and thus prevents DNase
I cleavage or Tn5 insertion. DNase-seq and ATAC-seq have
therefore also been used to study TF occupancy genome-
wide at nucleotide resolution by “TF footprinting” [14]
(Leiz et al., this issue). The reliability of both DNase- and
ATAC-seq for this purpose is influenced by sequence cleav-
age biases of the enzymes [15], meaning that they are not
always applicable and that successwill dependon the con-
dition and type of TF [16].
Activity of candidate regions
DNase- and ATAC-seq assays reveal accessible genomic
loci, but they do not distinguish between different kinds
of regulatory regions and their activity, i. e., if they are en-
gaged in regulating a gene in a particular context. The
regulatory state of a region is however reflected in pat-
terns of histone modifications. DNA is wrapped around
a nucleosome core, which is a tetramer composed of dif-
ferent histone proteins with tails that can be modified,
most frequently bymethylation or acetylation. Thesemod-
ifications serve as road signs for gene regulation. Us-
ing Chromatin ImmunoPrecipitation (ChIP), Hebbes et al.
(1988) first established a direct link between core histone
acetylation and transcriptionally active chromatin [17]. As
more and more types of histone modifications were dis-
covered, scientists put forward the existence of a “his-
tone code,” in contrast to the “genetic code,” which or-
chestrates the transcriptional program of the invariant
genome. Table 1 lists the best-known and most robust hi-
stone marks. Due to the specificity of antibody–antigen
recognition, ChIP has been successfully adapted to the
genome-wide profiling of histone modifications, histone
variants, andDNAmethylation. Thismethod is called ChIP
sequencing (ChIP-seq), where all the DNA fragments are
sequenced that are precipitated with the protein of in-
terest, e. g., a transcription factor or a modified histone.
This allows bioinformatics to remap the position in the
genome from where the respective chromatin fragments
were precipitated. Figure 2 shows a schematic genome
browser view of the human MYOD1 locus with RNA se-
quencing (RNA-seq) tracks of plus and minus strands and
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Figure 2: Schematic depiction of the browser view of the human MYOD1 locus, overlaid with RNA-seq, CTCF ChIP-seq, and various histone
ChIP-seq tracks. Sequencing data were generated from human myotubes in culture by the ENCODE Consortium. For the gene annotation
track at the top, blue indicates protein coding genes, thick bars protein coding regions (exons), narrow bars untranslated regions (UTRs),
lines introns, and arrows the direction of transcription. RNA-seq signals of plus and minus strands are shown, as are the most common and
robust active and repressive histone marks. The positions of gene regulatory regions are depicted by vertical shades: promoters (blue),
enhancers (green), TAD boundaries (yellow), actively transcribed gene bodies (purple), and repressed gene bodies (gray). In this example
the geneMYOD1 is transcribed, while KCNC1 is repressed.
Table 1: Examples for frequent histone marks. The table lists the
names of five common histone marks, their preferred genomic lo-
cations, and their relations with respect to gene transcriptional
activity; e. g., H3K4me3 = trimethylation at the fourth lysine residue
of the histone H3 protein; H3K27ac = acetylation at the 27th lysine
residue of the histone H3 protein.
Histone mark Location Activity
H3K4me3 around the TSS active
H3K4me1/me2 at the enhancer active or primed
H3K27ac at the enhancer active
H3K36me3 within the gene body active
H3K27me3 at the promoter and
within the gene body
repressive
ChIP-seq tracks of CTCF, H3K4me, H3K4me3, H3K27ac,
H3K27me3, andH3K36me3 generated by the ENCODECon-
sortium from a human myotube culture derived from a
skeletal muscle myoblast line.
DNA methylation has long been associated with gene
repression, but research over the course of the past
decades has shown that DNA methylation participates
in multiple cellular functions, some of which are still
not fully understood. These include repression of trans-
posons, inactivation of the X-chromosome, and genomic
imprinting. Most DNA methylation happens at CpG din-
ucleotides. This short palindromic sequence instructs
the methylation of daughter strands during DNA replica-
tion.
Methylation is classically investigated by bisulfite se-
quencing [18]. Treatment with bisulfite before sequencing
converts cytosine residues to uracil with the exception of
5-methyl-cytosines. Therefore, only methylated cytosines
are retained. The computational comparison of sequence
reads from treated and untreated DNA samples allows the
exact determination of CpG positions at single-nucleotide
resolution. NGS allows genome-wide analysis of methyla-
tion patterns, a method called Bis-seq [19].
The lowoverall percentage of CpGdinucleotides in the
mammaliangenomestands in contrast to thehighpercent-
age found at CpG islands (CGIs), where CpG dinucleotides
cluster in genomic regions of about 1 kb. Over two thirds of
mammalian promoters, including almost all housekeep-
ing genes and several developmental genes, coincide with
CGIs. CGI promoters are rarely methylated; in these in-
stances, gene silencing is achieved by H3K27 methylation
[20]. While methylation of some TFBSs deters binding,
many TFs in the extended homeodomain family did prefer
methylated CpG in an in vitro assay [21]. Interestingly, the
mammalian genome rewrites itsmethylation pattern twice
during development, once after fertilization and once after
germline specification.
Through ENCODE and other concerted efforts to sys-
tematically profile the epigenomic landscapes in human
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Figure 3: Chromatin conformation capture methods profile long-range interactions between regulatory sequences, thereby identifying TADs.
(A) TADs can be repressed by binding of chromatin remodelers such as Polycomb Repressive Complex 2 (PRC2), which compacts the re-
gions and prevents transcription. (B) Depicted are two TADs, one active (green) and one repressed (red). In the active TAD, a long-range
promoter–enhancer interaction leads to active transcription. In the repressed TAD, silencing histone marks such as H3K27me3 recruit epige-
netic modifiers and chromatin remodelers such as PRC2 to compact chromatin, preventing transcription. TADs are identified by directional
ligation events in the 3C-based assays.
cell lines, primary cell types, and model systems, it be-
came obvious that the number of possible combinations
of histone combinations and other epigenetic states at ge-
nomic loci exceeded the capabilities of manual human ex-
ploration. This is therefore one area where computational
analyses, and in particular the use of machine learning,
has made a crucial impact. In 2010, Ernst and Kellis iden-
tified 51 “chromatin states” de novo with a simple combi-
natorial model of 38 histone modifications and other epi-
genetic information. These states fit with existing genomic
annotations [8], although subsequent publications have
proposed a less complex picture with fewer states [22, 23].
Regions in their spatial context
While distal regulatory regions can be confidently iden-
tified using chromatin accessibility analysis and ChIP-
seq for epigenetic marks, it is challenging to link them
to their target genes by this information alone. Distal re-
gions can be located far from their target promoters, up-
stream or downstream, exerting their function on possibly
multiple targets over large genomic distances. Advances
in genome-wide chromatin interaction profiling demon-
strated that many regulatory regions that are distal on the
linear genome come into close physical proximity as a re-
sult of chromatin looping andhigher-order organization of
the 3D structure of the chromatin (Figure 3A). Among these
technologies, Hi-C, a method based on chromatin confor-
mation capture (3C), and Chromatin Interaction Analysis
with Paired-End Tags (ChIA-PET) are two state-of-the-art
genome-wide assays for studying chromatin interactions
based on nuclear proximity ligation that enable the detec-
tion of genomic regulatory regions brought into close spa-
tial proximity by long-range chromatin looping.
Chromatin conformation capture methods investigate
the interaction between two loci (3C), between one locus
and the rest of the genome (4C), or between multiple loci
(5C). Hi-C is based on proximity ligation of cross-linked
DNAvia a biotin linker, which is also used to pull down the
DNA fragments, followed by high-throughput sequencing
[24]. Unlike previous approaches, Hi-C can, at least in the-
ory, capture all genome-wide chromatin interactions. Hi-C
studies revealed that the human genome is organized into
large TADs, where distal–proximal regulatory region in-
teractions are facilitated within the same TAD [25]. CTCF
and the cohesion complex play key roles in establishing
and maintaining TAD boundaries, the positions of which
are invariant in different cell types and whose disruption
can result in aberrant long-range distal–proximal regula-
tory region interactions (Krude et al., this edition), lead-
ing to dysregulation of target genes in disease conditions
[26, 27]. TADs as a whole can be repressed by binding of
chromatin remodelers, such as Polycomb Repressive Com-
plex 2 (PRC2), which compacts the chromatin and inhibits
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enhancer–promoter interactions (Figure 3B). While there
is a body of evidence supporting the concept of preferen-
tial intra-TAD promoter–enhancer contacts, recent stud-
ies identified significant promoter interactions with dis-
tal regulatory sites that crossed TAD boundaries, indicat-
ing that TAD boundaries can be overcome at certain inci-
dences [28, 29].
A main limitation of using Hi-C methods to study
distal–proximal regulatory region interactions is the ex-
tremely high number of sequencing reads required to
achieve a resolution necessary to resolve individual in-
teractions. Billions of reads are needed to reach the cur-
rent highest resolution of 5–10 kb. These limitations can
be overcome by Capture Hi-C (CHi-C), which enables inter-
action analysis of targeted regulatory regions by manage-
able amounts of sequencing data [30]. Alternatively, ChIA-
PET enriches for interactions associated with a particular
chromatinmodification or TF. Themethod can create high-
resolution (< 1 kb) maps of chromatin interactions medi-
ated by a protein of interest, thereby linking distal TFBSs
to their target genes [31].
Validating candidate variants
The “genetic code” for translation of nucleotide triplets
into amino acids has been known for decades. While the
impact of mutations on the protein coding function can
be linked to large numbers of clinical disease phenotypes,
there appears to be no straightforward “regulation code”
counterpart. Many enhancers can influence one gene, one
enhancer can affect several genes, and their joint activity
is encoded in the combination of functional sequence ele-
ments, their redundancy, and their relationship with each
other. To understand what the function of a particular dis-
tal region might be, genetics has long relied on reporter
assays. Applicable mostly in model systems and cell lines,
one candidate variant at a time is placed next to a reporter
gene that enables the quantification of its influence on the
expression of the reporter, such as a fluorescent protein.
While allowing for in vivo insights, interpretation of re-
porters is limited in a number of ways: candidate variants
(i) are typically tested outside of their native sequence and
chromatin context, (ii) may comprise one, or only a part
of a larger, regulatory region; and (iii) in the case of plas-
mid reporter constructs, are studied in the absence of chro-
matin.
To address the limited throughput, recent develop-
ments include massively parallel reporter assays that
streamline and scale up the cloning of functional can-
didate fragments next to the reporter gene, allowing for
readouts of thousands of fragments [32]. Placing short se-
quence fragments into the same controlled context holds
promise for eliminating unwanted noise, thereby facilitat-
ing an unbiased evaluation of the impact of sequence vari-
ants. One example is Self-Transcribing Active Regulatory
Region sequencing (STARR-seq). This method is based on
the knowledge that enhancers can work independently of
their relative locations. Placing an enhancer candidate se-
quence downstream of a minimal promoter enables active
enhancers to transcribe themselves, meaning that it can
be read out and quantified by RNA-seq [33]. In spite of the
limitations of these reporter assays, e. g., the differences
observed when placing the same sequence within native
chromatin or on plasmids [34], such data have laid the
foundation for promising computationalmodels that iden-
tify non-coding variants of clinical relevance [35].
To dissect the impact of a regulatory region within its
native genomic context, one of the most promising direc-
tions has been opened by CRISPR genome editing tools. As
is the case for protein coding genes, CRISPR editing can be
targeted to specifically alter regulatory regions by means
of complementary guide RNAs. As we often do not know
which individual sequence features are relevant, satura-
tion screens that introduce thousands ofmutations help to
comprehensively assay a larger genomic region, suchas an
entire TAD [36]. In pooled screens, the effect of a sequence
or chromatin change is detected by phenotypes such as
growth or proliferation [37]. In single-cell screens, the ef-
fect on gene expression is directly determined via single-
cell RNA-seq [38].
Alternatively, “epigenome editing” perturbs the chro-
matin state via the introduction of inhibitory or activating
marks (CRISPRi/a) [39]. In this approach, a dead Cas9 nu-
clease is fused to epigenomemodifier domains, such as hi-
stone (de)acetylases, and is directed to a specific genomic
location via a guide RNA [34]. As the whole regulatory re-
gion is affected instead of a small sequence, data acquisi-
tion scales better and interpretation is easier [40, 41].
Single-cell genomics
With the requirements on sample size and purity decreas-
ing, large consortia have made progress, moving from
profiling of immortalized cell lines (ENCODE [11]) to post
mortem fetal tissues (Roadmap [12]) and postmortem adult
samples of healthy organs (GTEx consortium [42]). Ge-
nomics protocols have traditionally required tens of thou-
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sands to millions of cells to generate high-quality data.
This meant that small cell populations, or short-lived
states during development, were either not well reflected
or entirely obscured in the averaged pictures resulting
from these approaches. This situation has changed rapidly
with the rise of single-cell genomics where sequencing
protocols on individual cells [43] using microfluidic de-
vices, liquid handling robotics, and/or clever multiplexed
experimental designs enable us to profile tens of thou-
sands and even millions of cells in a single experiment
[44]. In contrast to the traditional, single average dataset
generated from millions of cells and encompassing mil-
lions of short sequencing reads, each single-cell dataset
is composed of a limited number of reads in the range of
10,000 to 100,000 reads. However, obtaining tens of thou-
sands single-cell datasets from one experiment enables us
to uncover heterogeneous states and responses of neigh-
boring cells in a tissue [45].
Due to the highly parallel nature of these experiments,
protocols that could be implemented in a few steps were
adopted first, starting with RNA-seq for expression pro-
filing. Yet other protocols, such as single-cell ATAC-seq,
quickly followed and are now available as standardized
kits from commercial vendors. Meanwhile, large atlases of
gene expression and open chromatin in multiple systems
have been generated for multiple organs [46–48]. Bisul-
fite sequencing and ChIP-seq are also implemented, but
are not yet as widely adopted [44, 45]. With the possibil-
ity of obtaining high-resolution information from small,
complex, and primary samples, single-cell genomics will
transform basic genomics research and its clinical appli-
cations.
Since the start of genome sequencing projects, com-
putational biology algorithms have been indispensable
for organizing and interpreting today’s massive heteroge-
neous sources of data from bulk and single-cell experi-
ments. In particular, carefully designed and vetted ma-
chine learning methods hold great promise for interpret-
ing the complex rules of gene regulation that are spread
out over large genomic regions and involvemultiplemech-
anisms [35, 49]. As with other applications, a critical as-
pect of successful adaptation of this technique will be the
ability to explain physiology and provide meaningful in-
terpretations.
Conclusion
High-throughput biology, and in particular deep sequenc-
ing, hasmade exploring the vast space of non-protein cod-
ing genomic regions possible.We nowhave a large catalog
of candidate regulatory regions at our disposal, building
the foundation that will enable us to include non-coding
sequence variation into diagnostics and clinical practice
in the context of the underlying causes of rare diseases.
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